IBDEI0PV ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11628,2)
;;=^5002735
;;^UTILITY(U,$J,358.3,11629,0)
;;=I15.8^^46^563^18
;;^UTILITY(U,$J,358.3,11629,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11629,1,3,0)
;;=3^Secondary Hypertension,Other
;;^UTILITY(U,$J,358.3,11629,1,4,0)
;;=4^I15.8
;;^UTILITY(U,$J,358.3,11629,2)
;;=^5007074
;;^UTILITY(U,$J,358.3,11630,0)
;;=E27.5^^46^563^1
;;^UTILITY(U,$J,358.3,11630,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11630,1,3,0)
;;=3^Adrenomedullary Hyperfunction
;;^UTILITY(U,$J,358.3,11630,1,4,0)
;;=4^E27.5
;;^UTILITY(U,$J,358.3,11630,2)
;;=^5002744
;;^UTILITY(U,$J,358.3,11631,0)
;;=E26.01^^46^563^4
;;^UTILITY(U,$J,358.3,11631,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11631,1,3,0)
;;=3^Conn's Syndrome
;;^UTILITY(U,$J,358.3,11631,1,4,0)
;;=4^E26.01
;;^UTILITY(U,$J,358.3,11631,2)
;;=^329905
;;^UTILITY(U,$J,358.3,11632,0)
;;=I15.9^^46^563^19
;;^UTILITY(U,$J,358.3,11632,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11632,1,3,0)
;;=3^Secondary Hypertension,Unspec
;;^UTILITY(U,$J,358.3,11632,1,4,0)
;;=4^I15.9
;;^UTILITY(U,$J,358.3,11632,2)
;;=^5007075
;;^UTILITY(U,$J,358.3,11633,0)
;;=B20.^^46^564^3
;;^UTILITY(U,$J,358.3,11633,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11633,1,3,0)
;;=3^HIV Disease
;;^UTILITY(U,$J,358.3,11633,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,11633,2)
;;=^5000555
;;^UTILITY(U,$J,358.3,11634,0)
;;=J18.9^^46^564^6
;;^UTILITY(U,$J,358.3,11634,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11634,1,3,0)
;;=3^Pneumonia,Unspec Organism
;;^UTILITY(U,$J,358.3,11634,1,4,0)
;;=4^J18.9
;;^UTILITY(U,$J,358.3,11634,2)
;;=^95632
;;^UTILITY(U,$J,358.3,11635,0)
;;=J10.1^^46^564^1
;;^UTILITY(U,$J,358.3,11635,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11635,1,3,0)
;;=3^Flu w/ Respiratory Manifestations
;;^UTILITY(U,$J,358.3,11635,1,4,0)
;;=4^J10.1
;;^UTILITY(U,$J,358.3,11635,2)
;;=^5008151
;;^UTILITY(U,$J,358.3,11636,0)
;;=K52.9^^46^564^2
;;^UTILITY(U,$J,358.3,11636,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11636,1,3,0)
;;=3^Gastroenteritis & Colitis,Noninfective,Unspec
;;^UTILITY(U,$J,358.3,11636,1,4,0)
;;=4^K52.9
;;^UTILITY(U,$J,358.3,11636,2)
;;=^5008704
;;^UTILITY(U,$J,358.3,11637,0)
;;=N12.^^46^564^7
;;^UTILITY(U,$J,358.3,11637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11637,1,3,0)
;;=3^Tubulo-Interstitial Nephritis
;;^UTILITY(U,$J,358.3,11637,1,4,0)
;;=4^N12.
;;^UTILITY(U,$J,358.3,11637,2)
;;=^5015575
;;^UTILITY(U,$J,358.3,11638,0)
;;=L97.509^^46^564^4
;;^UTILITY(U,$J,358.3,11638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11638,1,3,0)
;;=3^Non-Pressure Chr Ulcer Unspec Foot w/ Unspec Severity
;;^UTILITY(U,$J,358.3,11638,1,4,0)
;;=4^L97.509
;;^UTILITY(U,$J,358.3,11638,2)
;;=^5009544
;;^UTILITY(U,$J,358.3,11639,0)
;;=M86.10^^46^564^5
;;^UTILITY(U,$J,358.3,11639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11639,1,3,0)
;;=3^Osteomylitis,Acute,Unspec Site
;;^UTILITY(U,$J,358.3,11639,1,4,0)
;;=4^M86.10
;;^UTILITY(U,$J,358.3,11639,2)
;;=^5014521
;;^UTILITY(U,$J,358.3,11640,0)
;;=E85.9^^46^565^1
;;^UTILITY(U,$J,358.3,11640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11640,1,3,0)
;;=3^Amyloidosis,Unspec
;;^UTILITY(U,$J,358.3,11640,1,4,0)
;;=4^E85.9
;;^UTILITY(U,$J,358.3,11640,2)
;;=^334185
;;^UTILITY(U,$J,358.3,11641,0)
;;=N00.9^^46^565^3
;;^UTILITY(U,$J,358.3,11641,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PV 3758 printed Dec 13, 2024@01:53:26 Page 2
IBDEI0PV ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11628,2)
+2 ;;=^5002735
+3 ;;^UTILITY(U,$J,358.3,11629,0)
+4 ;;=I15.8^^46^563^18
+5 ;;^UTILITY(U,$J,358.3,11629,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,11629,1,3,0)
+8 ;;=3^Secondary Hypertension,Other
+9 ;;^UTILITY(U,$J,358.3,11629,1,4,0)
+10 ;;=4^I15.8
+11 ;;^UTILITY(U,$J,358.3,11629,2)
+12 ;;=^5007074
+13 ;;^UTILITY(U,$J,358.3,11630,0)
+14 ;;=E27.5^^46^563^1
+15 ;;^UTILITY(U,$J,358.3,11630,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,11630,1,3,0)
+18 ;;=3^Adrenomedullary Hyperfunction
+19 ;;^UTILITY(U,$J,358.3,11630,1,4,0)
+20 ;;=4^E27.5
+21 ;;^UTILITY(U,$J,358.3,11630,2)
+22 ;;=^5002744
+23 ;;^UTILITY(U,$J,358.3,11631,0)
+24 ;;=E26.01^^46^563^4
+25 ;;^UTILITY(U,$J,358.3,11631,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,11631,1,3,0)
+28 ;;=3^Conn's Syndrome
+29 ;;^UTILITY(U,$J,358.3,11631,1,4,0)
+30 ;;=4^E26.01
+31 ;;^UTILITY(U,$J,358.3,11631,2)
+32 ;;=^329905
+33 ;;^UTILITY(U,$J,358.3,11632,0)
+34 ;;=I15.9^^46^563^19
+35 ;;^UTILITY(U,$J,358.3,11632,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,11632,1,3,0)
+38 ;;=3^Secondary Hypertension,Unspec
+39 ;;^UTILITY(U,$J,358.3,11632,1,4,0)
+40 ;;=4^I15.9
+41 ;;^UTILITY(U,$J,358.3,11632,2)
+42 ;;=^5007075
+43 ;;^UTILITY(U,$J,358.3,11633,0)
+44 ;;=B20.^^46^564^3
+45 ;;^UTILITY(U,$J,358.3,11633,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,11633,1,3,0)
+48 ;;=3^HIV Disease
+49 ;;^UTILITY(U,$J,358.3,11633,1,4,0)
+50 ;;=4^B20.
+51 ;;^UTILITY(U,$J,358.3,11633,2)
+52 ;;=^5000555
+53 ;;^UTILITY(U,$J,358.3,11634,0)
+54 ;;=J18.9^^46^564^6
+55 ;;^UTILITY(U,$J,358.3,11634,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,11634,1,3,0)
+58 ;;=3^Pneumonia,Unspec Organism
+59 ;;^UTILITY(U,$J,358.3,11634,1,4,0)
+60 ;;=4^J18.9
+61 ;;^UTILITY(U,$J,358.3,11634,2)
+62 ;;=^95632
+63 ;;^UTILITY(U,$J,358.3,11635,0)
+64 ;;=J10.1^^46^564^1
+65 ;;^UTILITY(U,$J,358.3,11635,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,11635,1,3,0)
+68 ;;=3^Flu w/ Respiratory Manifestations
+69 ;;^UTILITY(U,$J,358.3,11635,1,4,0)
+70 ;;=4^J10.1
+71 ;;^UTILITY(U,$J,358.3,11635,2)
+72 ;;=^5008151
+73 ;;^UTILITY(U,$J,358.3,11636,0)
+74 ;;=K52.9^^46^564^2
+75 ;;^UTILITY(U,$J,358.3,11636,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,11636,1,3,0)
+78 ;;=3^Gastroenteritis & Colitis,Noninfective,Unspec
+79 ;;^UTILITY(U,$J,358.3,11636,1,4,0)
+80 ;;=4^K52.9
+81 ;;^UTILITY(U,$J,358.3,11636,2)
+82 ;;=^5008704
+83 ;;^UTILITY(U,$J,358.3,11637,0)
+84 ;;=N12.^^46^564^7
+85 ;;^UTILITY(U,$J,358.3,11637,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,11637,1,3,0)
+88 ;;=3^Tubulo-Interstitial Nephritis
+89 ;;^UTILITY(U,$J,358.3,11637,1,4,0)
+90 ;;=4^N12.
+91 ;;^UTILITY(U,$J,358.3,11637,2)
+92 ;;=^5015575
+93 ;;^UTILITY(U,$J,358.3,11638,0)
+94 ;;=L97.509^^46^564^4
+95 ;;^UTILITY(U,$J,358.3,11638,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,11638,1,3,0)
+98 ;;=3^Non-Pressure Chr Ulcer Unspec Foot w/ Unspec Severity
+99 ;;^UTILITY(U,$J,358.3,11638,1,4,0)
+100 ;;=4^L97.509
+101 ;;^UTILITY(U,$J,358.3,11638,2)
+102 ;;=^5009544
+103 ;;^UTILITY(U,$J,358.3,11639,0)
+104 ;;=M86.10^^46^564^5
+105 ;;^UTILITY(U,$J,358.3,11639,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,11639,1,3,0)
+108 ;;=3^Osteomylitis,Acute,Unspec Site
+109 ;;^UTILITY(U,$J,358.3,11639,1,4,0)
+110 ;;=4^M86.10
+111 ;;^UTILITY(U,$J,358.3,11639,2)
+112 ;;=^5014521
+113 ;;^UTILITY(U,$J,358.3,11640,0)
+114 ;;=E85.9^^46^565^1
+115 ;;^UTILITY(U,$J,358.3,11640,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,11640,1,3,0)
+118 ;;=3^Amyloidosis,Unspec
+119 ;;^UTILITY(U,$J,358.3,11640,1,4,0)
+120 ;;=4^E85.9
+121 ;;^UTILITY(U,$J,358.3,11640,2)
+122 ;;=^334185
+123 ;;^UTILITY(U,$J,358.3,11641,0)
+124 ;;=N00.9^^46^565^3
+125 ;;^UTILITY(U,$J,358.3,11641,1,0)
+126 ;;=^358.31IA^4^2
